This Avenir Award from the National Institute on Drug Abuse (NIDA) is specifically designed to support outstanding early-stage investigators in the field of chemistry and pharmacology of substance use disorders. This grant aims to enable researchers who demonstrate promise as future leaders to pursue high-impact, innovative, and transformative research, even if they lack the extensive preliminary data typically required for an R01 grant. The program encourages leveraging recent advancements in chemical, pharmacological, and drug discovery technologies to identify novel targets, mechanisms, and pathways. It seeks to foster cutting-edge research leading to the development of novel therapeutic agents for substance use disorders by those knowledgeable in emerging chemical and pharmacological approaches.
Opportunity ID: 344128
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-24-007 |
| Funding Opportunity Title: | Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 20, 2022 |
| Last Updated Date: | Oct 20, 2022 |
| Original Closing Date for Applications: | Aug 07, 2025 |
| Current Closing Date for Applications: | Aug 07, 2025 |
| Archive Date: | Sep 12, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses State governments Small businesses Special district governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | oThe goal of this FOA is to attract outstanding early-stage investigators to the field of chemistry and pharmacology of substance used disorders. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow’s leaders in the field. In recent years, there have been significant advances in methods and technologies for the identification of novel targets, mechanisms, and pathways of interest to substance use disorders and in identification of probes and optimized compounds for developing novel therapeutic agents. This FOA is to enable investigators with knowledge in the emerging chemical, pharmacological, and drug discovery technologies to pursue innovative and transformative research on chemical and pharmacological aspects of substance use disorders. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 344128 Full Announcement-RFA-DA-24-007 -> RFA-DA-24-007-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00277378 | Jul 09, 2023 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00278535 | Jul 09, 2023 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289384 | Dec 03, 2024 | Aug 07, 2025 | View |
Package 1
Mandatory forms
344128 RR_SF424_5_0-5.0.pdf
344128 PerformanceSite_4_0-4.0.pdf
344128 RR_OtherProjectInfo_1_4-1.4.pdf
344128 RR_KeyPersonExpanded_4_0-4.0.pdf
344128 PHS398_CoverPageSupplement_5_0-5.0.pdf
344128 PHS398_ResearchPlan_5_0-5.0.pdf
344128 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344128 PHS_AssignmentRequestForm_4_0-4.0.pdf
344128 RR_Budget10_3_0-3.0.pdf
344128 RR_SubawardBudget10_30_3_0-3.0.pdf
344128 PHS398_ModularBudget_1_2-1.2.pdf
Package 2
Mandatory forms
344128 RR_SF424_5_0-5.0.pdf
344128 PerformanceSite_4_0-4.0.pdf
344128 RR_OtherProjectInfo_1_4-1.4.pdf
344128 RR_KeyPersonExpanded_4_0-4.0.pdf
344128 PHS398_CoverPageSupplement_5_0-5.0.pdf
344128 PHS398_ResearchPlan_4_0-4.0.pdf
344128 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344128 PHS_AssignmentRequestForm_3_0-3.0.pdf
344128 RR_Budget10_3_0-3.0.pdf
344128 RR_SubawardBudget10_30_3_0-3.0.pdf
344128 PHS398_ModularBudget_1_2-1.2.pdf
Package 3
Mandatory forms
344128 RR_SF424_5_0-5.0.pdf
344128 PerformanceSite_4_0-4.0.pdf
344128 RR_OtherProjectInfo_1_4-1.4.pdf
344128 RR_KeyPersonExpanded_4_0-4.0.pdf
344128 PHS398_CoverPageSupplement_5_0-5.0.pdf
344128 PHS398_ResearchPlan_5_0-5.0.pdf
344128 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344128 PHS_AssignmentRequestForm_3_0-3.0.pdf
344128 RR_Budget10_3_0-3.0.pdf
344128 RR_SubawardBudget10_30_3_0-3.0.pdf
344128 PHS398_ModularBudget_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
